Acquired <i>RAD51C</i> Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian CarcinomaKsenija Nesic, Clare L. Scott, Cassandra J. Vandenberg et al.|Cancer Research|2021Cited by 91
Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with EribulinGwo‐Yaw Ho, Holly E. Barker, Elizabeth L. Kyran et al.|Cancer Research|2022Cited by 26